ArticleSensors (Basel, Switzerland)2026
LPFG Biosensor for IL-6 Detection in Murine Serum Samples Associated with Ischemic Disease.
Article in Sensors (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Nowadays, optical fiber-based biosensors are widely used in various fields, particularly in medical diagnostics and the selection of appropriate treatments for certain diseases. One example is cerebral ischemic disease, where many biomarkers are released and provide valuable information about the severity and progression of the disease. In this study, a long-period fiber grating (LPFG) biosensor was developed using a standard single-mode optical fiber and monoclonal antibody (IL-6 mAb) as the biological recognition element to detect IL-6, which is a protein associated with the inflammatory process. The assembly of the LPFG biosensor was characterized through optical and electronic microscopy to observe morphological changes at different stages of fabrication and the detection process. Additionally, micro-infrared spectroscopy was employed to identify functional groups in the protein region linked to the presence of IL-6. Experimental data were analyzed using principal component analysis, confirming the biosensor's ability to detect IL-6 and providing insights into its fabrication process.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.